GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Other Gross PPE

Sumitomo Pharma Co (Sumitomo Pharma Co) Other Gross PPE : $410 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Other Gross PPE?

Sumitomo Pharma Co's Other Gross PPE for the quarter that ended in Dec. 2023 was $410 Mil.

Sumitomo Pharma Co's quarterly Other Gross PPE declined from Jun. 2023 ($425 Mil) to Sep. 2023 ($407 Mil) but then increased from Sep. 2023 ($407 Mil) to Dec. 2023 ($410 Mil).

Sumitomo Pharma Co's annual Other Gross PPE declined from Mar. 2021 ($598 Mil) to Mar. 2022 ($540 Mil) and declined from Mar. 2022 ($540 Mil) to Mar. 2023 ($441 Mil).


Sumitomo Pharma Co Other Gross PPE Historical Data

The historical data trend for Sumitomo Pharma Co's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Other Gross PPE Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 535.21 610.66 597.67 540.50 440.72

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 440.80 440.72 424.81 407.20 409.91

Sumitomo Pharma Co Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.